Tonix Pharmaceuticals Holding (TNXP) EBITDA Margin (2011 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted EBITDA Margin of -309.48% for Q2 2026, up 993.87 percentage points from -1303.35% a year earlier and up 286.36 percentage points from the prior quarter.
Tonix Pharmaceuticals Holding (TNXP) EBITDA Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Tonix Pharmaceuticals Holding was -561.14%, up 233.86 percentage points year-over-year; for FY2025, it came in at -930.35%, up 381.72 percentage points from FY2024.
- In prior years, Tonix Pharmaceuticals Holding's EBITDA Margin was -1312.07% in FY2024 (+156.64 pp) and -1468.70% in FY2023.
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q2 2011.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +352.79 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2025, with a gain of 2137.86 percentage points; the weakest was Q3 2025, with a drop of 465.37 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -595.84% (Q1 2026), -886.79% (Q4 2025) and -991.06% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Tonix Pharmaceuticals Holding | 74.61 Mn | -684.78 Mn | 12.84 Mn | -309.48% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -309.48% |
| Mar 31, 2026 | -595.84% |
| Dec 31, 2025 | -886.79% |
| Sep 30, 2025 | -991.06% |
| Jun 30, 2025 | -1,303.35% |
| Mar 31, 2025 | -637.96% |
| Dec 31, 2024 | -843.69% |
| Sep 30, 2024 | -525.69% |
| Jun 30, 2024 | -3,441.21% |
| Mar 31, 2024 | -799.32% |
| Dec 31, 2023 | -689.81% |
| Sep 30, 2023 | -675.13% |
| Dec 31, 2015 | -31,845.24% |
| Sep 30, 2015 | -44,186.67% |
| Jun 30, 2015 | -56,004.76% |
| Mar 31, 2015 | -64,493.33% |
| Dec 31, 2014 | -59,886.67% |
| Sep 30, 2014 | -49,520.00% |
| Jun 30, 2014 | -120,880.00% |
| Mar 31, 2014 | -103,300.00% |
Tonix Pharmaceuticals Holding EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();